3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
6
Polycystic Ovary Syndrome
2
Obesity
2
Diabetes Mellitus
2
Stroke
1
Sedentary Behavior
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Osteoporosis
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Kidney Diseases
1
Insulin Resistance
1
Hypertension
1
Heart Failure
1
Frailty
1
Endometrial Neoplasms
1
Diabetes Mellitus, Type 2
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Body Weight
1
Arthritis
1
Interventions
Lenalidomide
8
Dexamethasone
6
Calcium Dobesilate
6
Melphalan
3
elotuzumab
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
daratumumab
2
auricularum
2
Peripheral Blood Stem Cell Transplantation
2
Bortezomib
2
pomalidomide
1
piperine
1
pembrolizumab
1
ixazomib
1
ibrutinib
1
Watchful Waiting
1
Urination
1
Transplantation, Autologous
1
Stem Cell Transplantation
1
Receptors, Interleukin-6
1
Observation
1
Nivolumab
1
Metformin
1
Interleukin 1 Receptor Antagonist Protein
1
In Situ Hybridization, Fluorescence
1
IPH-2101
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Smoldering Multiple Myeloma
×
Resistance Training
×
Clear all
No trials found.